デフォルト表紙
市場調査レポート
商品コード
391373

世界の分子バイオセンサー市場:用途、技術、タイプ、地域別 - 成長、動向、予測

Molecular Biosensors Market - Growth, Trends, Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
世界の分子バイオセンサー市場:用途、技術、タイプ、地域別 - 成長、動向、予測
出版日: 2020年02月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2~3営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の分子バイオセンサー市場は、2018年から2023年にかけて、7.5%のCAGRで推移するものと予測されています。地域別では、ナノテクノロジー領域における分子バイオセンサーの用途拡大を背景に、北米が最大市場として台頭しています。

当レポートでは、世界の分子バイオセンサー市場を調査し、市場の概要、用途・技術・タイプ・地域別の市場規模の推移と予測、市場動向、成長要因・阻害要因ならびに市場機会・課題の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場の概要

  • 現在の市場シナリオ
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第6章 成長要因、阻害要因、機会、課題の分析

  • 市場の成長要因
    • 慢性疾患および生活習慣病の有病率の上昇
    • POC検査の需要増加
    • 各種産業におけるバイオセンサーの応用拡大
  • 市場の阻害要因
    • バイオセンサーの厳格な規制要件
    • 償還制度の問題
  • 市場機会
  • 主な課題

第7章 市場セグメンテーション

  • 用途別
    • 医療診断
    • 製薬・バイオ製薬
    • 食品・飲料
    • 環境安全
    • 防衛・セキュリティ
    • その他
  • 技術別
    • 電気化学的バイオセンサー
    • 光学バイオセンサー
    • 熱バイオセンサー
    • 圧電バイオセンサー
  • タイプ別
    • 生体シグナル伝達
    • 伝達要素
    • 認識要素
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第8章 競合情勢

  • 合併および買収分析
  • 合意、コラボレーション、パートナーシップ
  • 新製品の発売

第9章 主要プレーヤー

  • Abbott Laboratories Inc.
  • Bayer AG
  • F. Hoffmann La Roche
  • Johnson and Johnson
  • LifeSensors Inc.
  • Medtronic Inc.
  • Nova biomedical Corporation
  • Siemens Healthcare

第10章 市場の将来展望

目次
Product Code: 48746

A molecular biosensor is a device that uses specific biochemical reactions mediated by isolated enzymes, immunosystems, tissues, organelles or whole cells to detect chemical compounds usually by electrical, thermal or optical signals. Molecular biosensors are, thus, able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread

In recent years, due to ti increasing prevalence of chronic diseases, demand for point-of-care diagnostics has increased. This has led to an increase in demand for molecular biosensors. The factors have resulted in increased adoption of the molecular biosensor, which has helped the market growth.

However, high costs involved in research and development and strict regulatory guidelines to by authorities dissuade many manufacturers to enter the market. This has hindered the growth rate of the market.

Key Market Trends

Electrochemical Biosensors is Expected to Dominate the Market

Electrochemical biosensors have emerged as reliable molecular sensing devices suitable for the detection of pathogens in liquid biopsies. Short assay time, simple handling, low cost, small sample requirement, the ibility of multiplexing and miniaturization and good performance in complex samples with minimal pre-treatments justify their increasing growing and suitability for POC applications. These biosensors are able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread.

Pathogens are microorganisms that cause infectious disease. Bacteria and viruses are the main pathogens. Bacteria release toxins, and viruses damage cells. White blood cells destroy pathogens by ingestion or producing antibodies against them and antitoxins to neutralize toxins. Recently, due to unhealthy living conditions, especially in developing and underdeveloped countries, the incidence of bacterial infection has increased. Even in developed countries like the United States, the incidence of campylobacter gram-negative bacteria infection increased from 12.82 in 2004 to 12.97 in 2009 to 13.29 in 2014, according to a 2016 report by the Centers for Disease Control and Prevention.

Hence with increase in infection from pathogens, the demand for fast PoC diagnostics like electrochemical biosensors is expected to increase

North America is Expected to Dominate the Market

The North American countries of the United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.

Competitive Landscape

Majority of the molecular biosensors are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic and Lifestyle Induced Diseases
    • 4.2.2 Increasing Demand for Point of Care Testing
    • 4.2.3 Increasing Application of Biosensors in Various Industries
  • 4.3 Market Restraints
    • 4.3.1 Strict Regulatory Requirements for Biosensors
    • 4.3.2 High Cost Involved in Research and Development
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Electrochemical Biosensors
    • 5.1.2 Optical Biosensors
    • 5.1.3 Thermal Biosensors
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Medical Diagnostics
    • 5.2.2 Food and Beverages
    • 5.2.3 Environment Safety
    • 5.2.4 Defense and Security
    • 5.2.5 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories Inc.
    • 6.1.2 Dynamic Biosensors GmbH
    • 6.1.3 Bio-Rad Laboratories Inc
    • 6.1.4 F. Hoffmann La Roche
    • 6.1.5 Johnson and Johnson
    • 6.1.6 LifeSensors Inc.
    • 6.1.7 Medtronic Inc.
    • 6.1.8 Nova biomedical Corporation
    • 6.1.9 Siemens Healthcare
    • 6.1.10 Sysmex Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS